PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25919F0008Pharmaceutical reverse distribution and — Returns 'R' Us, Inc

PoP ended Oct 8, 2019 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Network Contract Office 19 (36C259)

Awarding office

Returns 'R' Us, Inc

Recipient

Oct 8, 2019

PoP end

$-18,633.07

Obligated

$258K

Potential

493110

NAICS

R499

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Returns 'R' Us, Inc — $90

Contract facts

Federal

Contract number36C25919F0008

Also listed as36C259-19-F-0008

Also listed as36W79718D0002-36C25919F0008

AgencyNetwork Contract Office 19 (36C259)

Awarding officeNetwork Contract Office 19 (36C259)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentReturns 'R' Us, Inc

CAGE1PUE0

UEID4VCRL38H9C9

NAICS493110

No full NAICS 493110 intel page yet. Browse NAICS intelligence

PSCR499

Parent IDIQ / IDV36W79718D0002

Place of performanceAURORA CO

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startOct 9, 2018

PoP end (current)Oct 8, 2019

Obligated$-18,633.07

Current value$258K

Potential value$258K

PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION is a federal award for Network Contract Office 19 (36C259) held by Returns 'R' Us, Inc. Estimated value $258K ($-18,633.07 obligated). Current period of performance ends Oct 8, 2019. Place of performance: AURORA CO.

PHARMACEUTICAL REVERSE DISTRIBUTION AND DESTRUCTION

Recompete timing

Public

● Past PoP end (2509 days ago)

Current PoP ended Oct 8, 2019 (2509 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25919F0008?

36C25919F0008 (Pharmaceutical reverse distribution and) is a Network Contract Office 19 (36C259) award with a potential value of $258K, currently held by Returns 'R' Us, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C259-19-F-0008?

36C259-19-F-0008 is the dashed form of PIID 36C25919F0008 (Pharmaceutical reverse distribution and), held by Returns 'R' Us, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25919F0008?

Network Contract Office 19 (36C259) awarded 36C25919F0008 to Returns 'R' Us, Inc (potential $258K).

Who is the incumbent on 36C25919F0008?

Returns 'R' Us, Inc is the incumbent. The current period of performance ends Oct 8, 2019.

When does Returns 'R' Us, Inc’s 36C25919F0008 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 8, 2019. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Feb 3, 2022 · refreshed monthly